Immunology: Identifying a nuclear passport for HIV
Cells have many ways to fight pathogens, but they still manage to evade our defenses. HIV, for example, is able to enter a cell, cross the cytoplasm, and then pass through the nuclear pore complex to reach the cell nucleus. The DNA within the virus is surrounded by a capsid that protects against defense mechanisms of the host, such as nucleic acid sensors and nucleases (Yan et al., 2010; Jacques et al., 2016; Francis and Melikyan, 2018; Burdick et al., 2017; Rasaiyaah et al., 2013).
Previously, it was thought that the capsid cannot enter the nucleus, but demonstration that the capsid depends on a nuclear protein called CPSF6 suggested that it might (Price et al., 2014; Lee et al., 2010). Now, in eLife, Hans-Georg Kräusslich and colleagues – including David Alejandro Bejarano and Ke Peng as joint first authors – report new insights into the role of CPSF6 and the entry of the capsid into the nucleus (Bejarano et al., 2019). The researchers – who are based at the University of Heidelberg and the Chinese Academy of Sciences – tagged HIV molecules with fluorescent markers and observed how HIV infected macrophages. The capsids and CPSF6 proteins were labeled with antibodies.
Bejarano et al. found that, contrary to previous assumptions, CPSF6 is essential for HIV to travel through the nuclear pore into the nucleus of macrophages. They also found that CPSF6 associated with capsids inside the nucleus, suggesting that intact capsids may cross the nuclear pore. When CPSF6 was depleted, or could no longer bind to the capsid, the virus accumulated outside the nucleus. This indicates a key role for CPSF6 in viral nuclear entry. However, similar to previous experiments, removing CPSF6 only modestly reduced the infection levels in macrophages because the capsids used the remaining low CPSF6 levels.
It is known that the capsid also binds a nuclear pore protein called Nup153 (Price et al., 2014). Bejarano et al. suggest that the capsid first interacts with Nup153 inside the nuclear pore complex; Nup153 is then displaced by nuclear CPSF6, which helps to pull the capsid inside the nucleus (Figure 1). They also propose an intriguing model to explain how the viral DNA could integrate into host DNA in the absence of CPSF6. In line with the hypotheses proposed in other studies (Achuthan et al., 2018; Schaller et al., 2011; Sowd et al., 2016), Bejarano et al. suggest that, in the absence of CPSF6, the capsid pokes through the nuclear pore complex enough for the integration of DNA to take place at the periphery of the nucleus.
Two key questions remain. First, why is CPSF6 required for replication in macrophages but not in cell lines? One reason for this might be that, in the absence of binding to a cofactor such as CPSF6, HIV-1 triggers the production of interferon in macrophages (Rasaiyaah et al., 2013). We can think of this in terms of cell lines 'licensing' otherwise 'illegal' behaviors by viruses. For example, capsid uncoating in the cytoplasm is 'illegal' in macrophages: that is, it does not lead to infection. However, such behaviour is licensed in cell lines and results in infection. This might be because, in macrophages, interferon suppresses mutant HIV-1 infection and uncoated cytosolic capsids are degraded. In cell lines, on the other hand, these 'illegal' viral behaviours are allowed and the virus can replicate.
Second, what is the role of CPSF6 in T cells (the immune cells that are the main target of HIV)? Given their small size and minimal cytoplasm, T cells are less suitable for microscopy, although nuclear transport can be studied in them (Achuthan et al., 2018). A better understanding of how HIV replicates in T cells, and where capsid uncoating occurs, may reveal fundamental differences in infection mechanisms between T cells and macrophages. In turn, this may help us understand the relative importance of HIV replication in macrophages and T cells in vivo.
This elegant study is a real technical tour de force, which has overcome significant experimental challenges to answer key questions in the field. As the techniques used by Bejarano et al. become widely adopted, we look forward to rapid advances in our understanding of the basic biology of HIV that may ultimately lead to more effective ways to treat, and eventually cure, HIV and AIDS.
References
-
Flexible use of nuclear import pathways by HIV-1Cell Host & Microbe 7:221–233.https://doi.org/10.1016/j.chom.2010.02.007
Article and author information
Author details
Publication history
Copyright
© 2019, Zuliani-Alvarez and Towers
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,681
- views
-
- 202
- downloads
-
- 4
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
The spatiotemporal transition of small GTPase Rab5 to Rab7 is crucial for early-to-late endosome maturation, yet the precise mechanism governing Rab5-to-Rab7 switching remains elusive. USP8, a ubiquitin-specific protease, plays a prominent role in the endosomal sorting of a wide range of transmembrane receptors and is a promising target in cancer therapy. Here, we identified that USP8 is recruited to Rab5-positive carriers by Rabex5, a guanine nucleotide exchange factor (GEF) for Rab5. The recruitment of USP8 dissociates Rabex5 from early endosomes (EEs) and meanwhile promotes the recruitment of the Rab7 GEF SAND-1/Mon1. In USP8-deficient cells, the level of active Rab5 is increased, while the Rab7 signal is decreased. As a result, enlarged EEs with abundant intraluminal vesicles accumulate and digestive lysosomes are rudimentary. Together, our results reveal an important and unexpected role of a deubiquitinating enzyme in endosome maturation.
-
- Cancer Biology
- Cell Biology
Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.